Medical device company that is developing a catheter-based neuromodulation solution for the treatment of acute decompensated heart failure (ADHF).
Location: United States, Minnesota, New Brighton
Total raised: $20M
Investors 2
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | Ascension ... | ascensionv... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.10.2015 | Series A | $20M | - |
Mentions in press and media 3
| Date | Title | Description |
| 27.10.2015 | Cardionomic raises $20M in Series A financing | The goal with Cardionomic’s device is to treat ADHF at the root cause with electronic stimulation instead of relying on prescription drugs to get blood flowing properly. “Current ADHF approaches, all of which use drug therapies, inadequatel... |
| 27.10.2015 | Cardionomic Receives $20M in Series A Financing | Cardionomic, Inc., a Minneapolis, Minn.-based medical device developer, received $20m in Series A financing. Backers included New Enterprise Associates, the Cleveland Clinic, Greatbatch Inc., and others. The company intends to use the funds... |
| - | Cardionomic raises $20M in Series A financing | Twin Cities med-tech startup Cardionomic brought in a significant amount of money for its Series A financing with $20 million to contribute to the design of its minimally invasive medical device. It’s intended to be used in hospitals to tre... |